Adage Capital Partners Gp, L.L.C. Protara Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,250,000 shares of TARA stock, worth $9.56 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,250,000Holding current value
$9.56 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
60Shares Held
23.4MCall Options Held
58.3KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA3.4MShares$14.5 Million0.29% of portfolio
-
Janus Henderson Group PLC London, X02.27MShares$9.66 Million0.01% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A62.09MShares$8.88 Million0.02% of portfolio
-
Opaleye Management Inc. Boston, MA1.83MShares$7.76 Million1.88% of portfolio
-
Blackstone Inc New York, NY1.68MShares$7.14 Million0.04% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $47.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...